Xiaoyang Qi Selected Research

Therapeutics

2/2023	Electric Fields Regulate In Vitro Surface Phosphatidylserine Exposure of Cancer Cells via a Calcium-Dependent Pathway.
5/2022	Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy.
1/2022	RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy.
11/2021	SapC-DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents.
6/2021	Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.
1/2021	Reuse of Molecules for Glioblastoma Therapy.
1/2020	A barrier against reactive oxygen species: chitosan/acellular dermal matrix scaffold enhances stem cell retention and improves cutaneous wound healing.
1/2020	Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.
1/2020	SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.
3/2019	Acidic pH and High-H2O2 Dual Tumor Microenvironment-Responsive Nanocatalytic Graphene Oxide for Cancer Selective Therapy and Recognition.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyang Qi Research Topics

Disease

33	Neoplasms (Cancer) 02/2023 - 01/2004
8	Brain Neoplasms (Brain Tumor) 11/2021 - 08/2013
7	Glioblastoma (Glioblastoma Multiforme) 02/2023 - 08/2014
6	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023 - 01/2013
3	Obesity 12/2022 - 01/2022
3	Glioma (Gliomas) 01/2021 - 04/2015
3	Adenocarcinoma 01/2020 - 01/2014
3	Breast Neoplasms (Breast Cancer) 11/2019 - 09/2009
2	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2022
2	Wounds and Injuries (Trauma) 01/2020 - 01/2017
2	Neuroblastoma 04/2015 - 09/2009
1	Fistula 10/2023
1	Metabolic Diseases (Metabolic Disease) 12/2022
1	Carcinogenesis 05/2022
1	Body Weight (Weight, Body) 01/2022
1	Pancreatic Pseudocyst 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Cysts 01/2022
1	Colitis 04/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 05/2020
1	Gaucher Disease (Gaucher's Disease) 05/2020
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Fibrosis (Cirrhosis) 11/2017
1	Carcinoid Tumor (Carcinoid) 11/2017
1	Primitive Neuroectodermal Tumors (PNET) 11/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017
1	Disease Progression 11/2017
1	Fibula Fractures 01/2017
1	Distal Femoral Fractures 01/2017
1	Infections 01/2017

Drug/Important Bio-Agent (IBA)

20	PhosphatidylserinesIBA 02/2023 - 01/2012
17	SaposinsIBA 05/2022 - 09/2009
9	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2009
7	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2013
7	Phospholipids (Phosphatides)FDA LinkGeneric 02/2015 - 10/2011
6	LipidsIBA 11/2021 - 01/2004
4	Tumor Biomarkers (Tumor Markers)IBA 02/2023 - 04/2015
3	CalciumIBA 02/2023 - 10/2015
3	Messenger RNA (mRNA)IBA 02/2022 - 01/2014
3	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2017
2	MicroRNAs (MicroRNA)IBA 02/2022 - 04/2021
2	Temozolomide (Temodar)FDA LinkGeneric 11/2021 - 02/2017
2	EnzymesIBA 05/2020 - 09/2009
2	Fluorescent Dyes (Fluorescent Probes)IBA 10/2016 - 10/2011
2	Thromboplastin (Tissue Factor)IBA 05/2016 - 01/2014
2	CaspasesIBA 04/2015 - 09/2009
2	Contrast MediaIBA 04/2015 - 10/2011
1	p38 Mitogen-Activated Protein KinasesIBA 02/2023
1	Polyethylene (Polythene)IBA 02/2023
1	bavituximabIBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	Circular RNAIBA 02/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	AntralIBA 01/2022
1	Liposomes (Liposome)IBA 11/2021
1	Sulfonic AcidsIBA 04/2021
1	Benzene (Benzole)IBA 04/2021
1	VaccinesIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	AcidsIBA 05/2020
1	GlucosidasesIBA 05/2020
1	Albumin-Bound Paclitaxel FDA Link 01/2020
1	Gemcitabine FDA Link 01/2020
1	chondroitin 4-sulfotransferaseIBA 11/2019
1	GlycosaminoglycansIBA 11/2019
1	Long Noncoding RNAIBA 11/2019
1	Quinine (Quinson)FDA Link 03/2019
1	Peroxidase (Myeloperoxidase)IBA 03/2019
1	Hydroxyl RadicalIBA 03/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2019
1	graphene oxideIBA 03/2019
1	Dopamine (Intropin)FDA LinkGeneric 03/2019
1	MTOR InhibitorsIBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	CC-223IBA 11/2017
1	Sirolimus (Rapamycin)FDA Link 11/2017
1	Everolimus FDA Link 11/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2017
1	BI 2536IBA 02/2017
1	Alkylating AgentsIBA 02/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017

Therapy/Procedure

21	Therapeutics 02/2023 - 10/2011
3	Drug Therapy (Chemotherapy) 01/2022 - 04/2015
2	Gastrectomy 04/2022 - 01/2022
1	Aftercare (After-Treatment) 10/2023
1	Bariatric Surgery 12/2022
1	Punctures 01/2022
1	Glycemic Control 01/2022
1	Radiotherapy 11/2021
1	Enzyme Replacement Therapy 05/2020
1	Biological Therapy 01/2020
1	Surgical Amputation (Amputations) 01/2017
1	Arthrodesis 01/2017
1	Internal Fixators 01/2017
1	Debridement 01/2017